Literature DB >> 25770355

Quantifying behaviors of children with Sanfilippo syndrome: the Sanfilippo Behavior Rating Scale.

Elsa G Shapiro1, Igor Nestrasil2, Alia Ahmed2, Andrew Wey3, Kyle R Rudser3, Kathleen A Delaney2, Robin K Rumsey2, Patrick A J Haslett4, Chester B Whitley2, Michael Potegal2.   

Abstract

The Sanfilippo Behavior Rating Scale (SBRS), a 68 item questionnaire, has been developed to assess the behavioral phenotype of children with Sanfilippo syndrome and its progression over time. Fifteen scales rate orality, movement/activity, attention/self-control, emotional function including anger and fear, and social interaction. Items within scales intercorrelate; measures of internal consistency are adequate. Twelve scales are grouped into 4 abnormality clusters: Movement, Lack of fear, Social/emotional and Executive Dysfunction. A Loess age-trajectory analysis showed that Lack of Fear, Social/Emotional and Executive Dysfunction increased steadily with age; Orality and Mood/Anger/Aggression leveled off. Movement peaked around 6years, then declined as children's excessive/purposeless actions stopped. Compared with standard scales, SBRS Movement was appropriately associated with the Vineland Motor scale; SBRS Lack of Fear had significant associations with the Autism Diagnostic Observation Schedule (ADOS), indicating a symptom overlap between Sanfilippo syndrome and autism. This suggests that reduced fearfulness may be the most salient/sensitive SBRS marker of disease progression. Volumetric MRI showed that increased Lack of Fear was significantly associated with reduced amygdala volume, consistent with our hypothesis that the behavior seen in Sanfilippo syndrome is a variant of Klüver-Bucy syndrome. Hippocampal volume loss had twice the effect on Social-Emotional Dysfunction as amygdala loss, consistent with a hippocampal role in attachment and social emotions. In conclusion, the SBRS assesses the Sanfilippo behavioral phenotype; it can measure behavior change that accompanies disease progression and/or results from treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior phenotype; Behavior rating scale; Sanfilippo Syndrome

Mesh:

Year:  2015        PMID: 25770355      PMCID: PMC4390542          DOI: 10.1016/j.ymgme.2015.02.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  19 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Structural MR image processing using the BRAINS2 toolbox.

Authors:  Vincent A Magnotta; Greg Harris; Nancy C Andreasen; Daniel S O'Leary; William T C Yuh; Dan Heckel
Journal:  Comput Med Imaging Graph       Date:  2002 Jul-Aug       Impact factor: 4.790

3.  The influence of autonomic arousal and semantic relatedness on memory for emotional words.

Authors:  Tony W Buchanan; Joset A Etzel; Ralph Adolphs; Daniel Tranel
Journal:  Int J Psychophysiol       Date:  2006-01-19       Impact factor: 2.997

4.  Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece.

Authors:  Bénédicte Héron; Yann Mikaeloff; Roseline Froissart; Guillaume Caridade; Irène Maire; Catherine Caillaud; Thierry Levade; Brigitte Chabrol; François Feillet; Hélène Ogier; Vassili Valayannopoulos; Helen Michelakakis; Dimitrios Zafeiriou; Lucy Lavery; Ed Wraith; Olivier Danos; Jean-Michel Heard; Marc Tardieu
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

Review 5.  Management of mucopolysaccharidosis type III.

Authors:  M A Cleary; J E Wraith
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Amygdala volume correlates positively with fearfulness in normal healthy girls.

Authors:  Ellen A A van der Plas; Aaron D Boes; John A Wemmie; Daniel Tranel; Peg Nopoulos
Journal:  Soc Cogn Affect Neurosci       Date:  2010-02-11       Impact factor: 3.436

Review 7.  Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.

Authors:  Cynthia M Schumann; Melissa D Bauman; David G Amaral
Journal:  Neuropsychologia       Date:  2010-10-13       Impact factor: 3.139

8.  Adult attachment insecurity and hippocampal cell density.

Authors:  Markus Quirin; Omri Gillath; Jens C Pruessner; Lucas D Eggert
Journal:  Soc Cogn Affect Neurosci       Date:  2009-12-09       Impact factor: 3.436

9.  Early presentation in the mucopolysaccharide disorders.

Authors:  G A Colville; M A Bax
Journal:  Child Care Health Dev       Date:  1996-01       Impact factor: 2.508

10.  Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome.

Authors:  Kathleen A Delaney; Kyle R Rudser; Brianna D Yund; Chester B Whitley; Patrick A J Haslett; Elsa G Shapiro
Journal:  JIMD Rep       Date:  2013-11-05
View more
  14 in total

1.  Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions.

Authors:  Elsa Shapiro; Jessica Bernstein; Heather R Adams; Ann J Barbier; Teresa Buracchio; Peter Como; Kathleen A Delaney; Florian Eichler; Jonathan C Goldsmith; Melissa Hogan; Sarrit Kovacs; Jonathan W Mink; Joanne Odenkirchen; Melissa A Parisi; Alison Skrinar; Susan E Waisbren; Andrew E Mulberg
Journal:  Mol Genet Metab       Date:  2016-04-14       Impact factor: 4.797

2.  Behavioral deficits and cholinergic pathway abnormalities in male Sanfilippo B mice.

Authors:  Shih-Hsin Kan; Steven Q Le; Quang D Bui; Braeden Benedict; Jesse Cushman; Mark S Sands; Patricia I Dickson
Journal:  Behav Brain Res       Date:  2016-06-23       Impact factor: 3.332

3.  The Neurobehavioral Phenotype in Mucopolysaccharidosis Type IIIB: an Exploratory Study.

Authors:  E Shapiro; K King; A Ahmed; K Rudser; R Rumsey; B Yund; K Delaney; I Nestrasil; C Whitley; M Potegal
Journal:  Mol Genet Metab Rep       Date:  2016-03-01

4.  Development of the Tailored Rett Intervention and Assessment Longitudinal (TRIAL) database and the Rett Evaluation of Symptoms and Treatments (REST) Questionnaire.

Authors:  Paramala Santosh; Kate Lievesley; Federico Fiori; Jatinder Singh
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

5.  Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.

Authors:  Arunabha Ghosh; Elsa Shapiro; Stewart Rust; Kathleen Delaney; Samantha Parker; Adam J Shaywitz; Adelaida Morte; Gillian Bubb; Maureen Cleary; Tien Bo; Christine Lavery; Brian W Bigger; Simon A Jones
Journal:  Orphanet J Rare Dis       Date:  2017-06-26       Impact factor: 4.123

6.  Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.

Authors:  Hélène F E Gleitz; Claire O'Leary; Rebecca J Holley; Brian W Bigger
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

Review 7.  Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures.

Authors:  Thomas Morel; Stefan J Cano
Journal:  Orphanet J Rare Dis       Date:  2017-11-02       Impact factor: 4.123

8.  An Engineered sgsh Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA.

Authors:  Alon M Douek; Mitra Amiri Khabooshan; Jason Henry; Sebastian-Alexander Stamatis; Florian Kreuder; Georg Ramm; Minna-Liisa Änkö; Donald Wlodkowic; Jan Kaslin
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C.

Authors:  Alexey V Pshezhetsky
Journal:  Rare Dis       Date:  2015-05-21

Review 10.  Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.

Authors:  Rita Barone; Alessandra Pellico; Annarita Pittalà; Serena Gasperini
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.